Business Description
ImmunoCellular Therapeutics Ltd
NAICS : 541714
SIC : 8731
ISIN : US4525362046
Description
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimes deadly diseases. Its pipeline includes compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad-spectrum cytokine effects.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 10.92 | |||||
6-1 Month Momentum % | -9.52 | |||||
12-1 Month Momentum % | -34.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmunoCellular Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0.396 | ||
Beta | 0 | ||
Volatility % | 78.65 | ||
14-Day RSI | 10.92 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0.07 | ||
12-1 Month Momentum % | -34.48 | ||
52-Week Range (€) | 0.03 - 0.57 | ||
Shares Outstanding (Mil) | 41.93 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ImmunoCellular Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ImmunoCellular Therapeutics Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
ImmunoCellular Therapeutics Ltd Frequently Asked Questions
What is ImmunoCellular Therapeutics Ltd(FRA:KOL1)'s stock price today?
The current price of FRA:KOL1 is €0.04. The 52 week high of FRA:KOL1 is €0.57 and 52 week low is €0.03.
When is next earnings date of ImmunoCellular Therapeutics Ltd(FRA:KOL1)?
The next earnings date of ImmunoCellular Therapeutics Ltd(FRA:KOL1) is .
Does ImmunoCellular Therapeutics Ltd(FRA:KOL1) pay dividends? If so, how much?
ImmunoCellular Therapeutics Ltd(FRA:KOL1) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |